Allergy and Asthma Following Children Who Were Fed Supplemented Infant Formula

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Mead Johnson Nutrition
ClinicalTrials.gov Identifier:
NCT00740974
First received: August 22, 2008
Last updated: NA
Last verified: August 2008
History: No changes posted
  Purpose

Long-term cognitive outcome study of children who participated in randomized trials of LCP-supplemented formula during infancy.


Condition
Allergy
Asthma

Study Type: Observational

Resource links provided by NLM:


Further study details as provided by Mead Johnson Nutrition:

Primary Outcome Measures:
  • Prevalence of asthma and allergy related diagnosis in medical records during first 3 years of life. [ Time Frame: after first 3 years of life ]

  Eligibility

Ages Eligible for Study:   up to 12 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Study Population

children previously randomized in a clinical study consuming LCP-supplemented infant formula

Criteria

Inclusion Criteria:

  • children previously randomized in a clinical study consuming LCP-supplemented infant formula

Exclusion Criteria:

  • children who did not previously participate in a randomized clinical study consuming LCP-supplemented infant formula
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00740974

Locations
United States, Texas
Retina Foundation of the Southwest
Dallas, Texas, United States, 75231
Sponsors and Collaborators
Mead Johnson Nutrition
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00740974     History of Changes
Other Study ID Numbers: 8580
Study First Received: August 22, 2008
Last Updated: August 22, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hypersensitivity
Asthma
Immune System Diseases
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate

ClinicalTrials.gov processed this record on July 29, 2014